Compare $CTKB vs $TKNO | Chartloom

Compare

$CTKB vs $TKNO

Cytek Biosciences Inc · Alpha Teknova Inc

CTKB

Cytek Biosciences Inc

TKNO

Alpha Teknova Inc

Compare $CTKB vs $TKNO

Comparing Cytek Biosciences Inc and Alpha Teknova Inc

CTKBCytek Biosciences Inc

TKNOAlpha Teknova Inc

CTKBCytek Biosciences Inc

Market cap

$701M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.18x

Rev growth (TTM)

5.4%

YTD performance

10.4%

52W performance

39.2%

FCF yield

-1.7%

TKNOAlpha Teknova Inc

Market cap

$474M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

9.58x

Rev growth (TTM)

12.3%

YTD performance

126.7%

52W performance

66.5%

FCF yield

-1.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTKB

TKNO

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

TKNO

Alpha Teknova Inc

Market Cap

CTKB$701M

TKNO$474M

Enterprise Value

CTKB$637M

TKNO$481M

Price

CTKB$5.43

TKNO$8.84

P/E Ratio

CTKBN/A

TKNON/A

P/S Ratio

CTKB3.39x

TKNO10.84x

EV/Sales

CTKB3.08x

TKNO11.01x

EV/EBITDA

CTKB1,027.69x

TKNO0.00x

P/B Ratio

CTKB2.37x

TKNO7.71x

P/FCF Ratio

CTKBN/A

TKNON/A

EV/FCF

CTKB-52.35x

TKNO-65.43x

PEG Ratio

CTKBN/A

TKNON/A

Forward P/E (NTM)

CTKBN/A

TKNON/A

Forward P/S (NTM)

CTKB3.18x

TKNO9.58x

Revenue (TTM)

CTKB$207M

TKNO$44M

Revenue Growth (YoY)

CTKB5.4%

TKNO12.3%

Forward Rev Growth

CTKB6.1%

TKNO14.4%

Gross Margin (TTM)

CTKB53.2%

TKNO34.6%

Operating Margin (TTM)

CTKB0.0%

TKNO0.0%

EBITDA Margin (TTM)

CTKB-17.9%

TKNO-21.7%

Net Margin (TTM)

CTKB-39.0%

TKNO-38.4%

FCF Margin (TTM)

CTKB-5.9%

TKNO-16.8%

Net Income (TTM)

CTKB$-81M

TKNO$-17M

FCF (TTM)

CTKB$-12M

TKNO$-7M

EPS (TTM)

CTKB-$0.62

TKNO-$0.31

ROE (TTM)

CTKB-2353.0%

TKNO-2494.0%

ROA (TTM)

CTKB-1740.0%

TKNO-1653.0%

ROIC (TTM)

CTKB-2293.0%

TKNO-2086.0%

Cash

CTKB$74M

TKNO$6M

Debt

CTKB$10M

TKNO$13M

Net Cash/Debt

CTKB$64M

TKNO$-7M

Current Ratio (TTM)

CTKB4.48x

TKNO4.49x

Quick Ratio (TTM)

CTKB3.77x

TKNO3.32x

Debt/Equity (TTM)

CTKB0.03x

TKNO0.21x

Debt/Assets (TTM)

CTKB0.0%

TKNO0.0%

Interest Coverage (TTM)

CTKBN/A

TKNON/A

Net Debt/EBITDA (TTM)

CTKB0.00x

TKNO0.00x

Beta

CTKB1.15

TKNO0.93

52W Performance

CTKB39.2%

TKNO66.5%

YTD Performance

CTKB10.4%

TKNO126.7%

% from 52W High

CTKB-12.6%

TKNO-6.8%

% from 52W Low

CTKB64.0%

TKNO362.8%

Asset Turnover (TTM)

CTKB0.45x

TKNO0.43x

FCF Yield (TTM)

CTKB-1.7%

TKNO-1.6%

Earnings Yield (TTM)

CTKB-11.5%

TKNO-3.5%

Dividend Yield (TTM)

CTKBN/A

TKNON/A

Rule of 40

CTKB-0.4

TKNO-4.6

EV/GP/RG

CTKB0.61

TKNO2.35

Ticker research

View CTKB research View TKNO research

Metric	CTKB Cytek Biosciences Inc	TKNO Alpha Teknova Inc
Market & Valuation
Market Cap	$701M	$474M
Enterprise Value	$637M	$481M
Price	$5.43	$8.84
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	10.84x
EV/Sales	3.08x	11.01x
EV/EBITDA	1,027.69x	0.00x
P/B Ratio	2.37x	7.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-65.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	9.58x
Revenue & Growth
Revenue (TTM)	$207M	$44M
Revenue Growth (YoY)	5.4%	12.3%
Forward Rev Growth	6.1%	14.4%
Profitability
Gross Margin (TTM)	53.2%	34.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-21.7%
Net Margin (TTM)	-39.0%	-38.4%
FCF Margin (TTM)	-5.9%	-16.8%
Net Income (TTM)	$-81M	$-17M
FCF (TTM)	$-12M	$-7M
EPS (TTM)	-$0.62	-$0.31
ROE (TTM)	-2353.0%	-2494.0%
ROA (TTM)	-1740.0%	-1653.0%
ROIC (TTM)	-2293.0%	-2086.0%
Financial Health
Cash	$74M	$6M
Debt	$10M	$13M
Net Cash/Debt	$64M	$-7M
Current Ratio (TTM)	4.48x	4.49x
Quick Ratio (TTM)	3.77x	3.32x
Debt/Equity (TTM)	0.03x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	0.93
52W Performance	39.2%	66.5%
YTD Performance	10.4%	126.7%
% from 52W High	-12.6%	-6.8%
% from 52W Low	64.0%	362.8%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.43x
FCF Yield (TTM)	-1.7%	-1.6%
Earnings Yield (TTM)	-11.5%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-4.6
EV/GP/RG	0.61	2.35
Ticker research	View CTKB research	View TKNO research

Valuation

P/S Ratio

CTKB

3.39x

TKNO

10.84x

EV/FCF

TKNO

-65.43x

CTKB

-52.35x

Growth & revenue

Revenue Growth TTM

TKNO

12.3%

CTKB

5.4%

Forward Revenue Growth

TKNO

14.4%

CTKB

6.1%

Profitability & performance

Gross Margin

CTKB

53.2%

TKNO

34.6%

ROE

CTKB

-2353.0%

TKNO

-2494.0%

FCF Yield %

TKNO

-1.6%

CTKB

-1.7%

52-Week Performance

TKNO

66.5%

CTKB

39.2%

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

TKNO

Alpha Teknova Inc

Market Cap

CTKB$701M

TKNO$474M

Enterprise Value

CTKB$637M

TKNO$481M

Price

CTKB$5.43

TKNO$8.84

P/E Ratio

CTKBN/A

TKNON/A

P/S Ratio

CTKB3.39x

TKNO10.84x

EV/Sales

CTKB3.08x

TKNO11.01x

EV/EBITDA

CTKB1,027.69x

TKNO0.00x

P/B Ratio

CTKB2.37x

TKNO7.71x

P/FCF Ratio

CTKBN/A

TKNON/A

EV/FCF

CTKB-52.35x

TKNO-65.43x

PEG Ratio

CTKBN/A

TKNON/A

Forward P/E (NTM)

CTKBN/A

TKNON/A

Forward P/S (NTM)

CTKB3.18x

TKNO9.58x

Revenue (TTM)

CTKB$207M

TKNO$44M

Revenue Growth (YoY)

CTKB5.4%

TKNO12.3%

Forward Rev Growth

CTKB6.1%

TKNO14.4%

Gross Margin (TTM)

CTKB53.2%

TKNO34.6%

Operating Margin (TTM)

CTKB0.0%

TKNO0.0%

EBITDA Margin (TTM)

CTKB-17.9%

TKNO-21.7%

Net Margin (TTM)

CTKB-39.0%

TKNO-38.4%

FCF Margin (TTM)

CTKB-5.9%

TKNO-16.8%

Net Income (TTM)

CTKB$-81M

TKNO$-17M

FCF (TTM)

CTKB$-12M

TKNO$-7M

EPS (TTM)

CTKB-$0.62

TKNO-$0.31

ROE (TTM)

CTKB-2353.0%

TKNO-2494.0%

ROA (TTM)

CTKB-1740.0%

TKNO-1653.0%

ROIC (TTM)

CTKB-2293.0%

TKNO-2086.0%

Cash

CTKB$74M

TKNO$6M

Debt

CTKB$10M

TKNO$13M

Net Cash/Debt

CTKB$64M

TKNO$-7M

Current Ratio (TTM)

CTKB4.48x

TKNO4.49x

Quick Ratio (TTM)

CTKB3.77x

TKNO3.32x

Debt/Equity (TTM)

CTKB0.03x

TKNO0.21x

Debt/Assets (TTM)

CTKB0.0%

TKNO0.0%

Interest Coverage (TTM)

CTKBN/A

TKNON/A

Net Debt/EBITDA (TTM)

CTKB0.00x

TKNO0.00x

Beta

CTKB1.15

TKNO0.93

52W Performance

CTKB39.2%

TKNO66.5%

YTD Performance

CTKB10.4%

TKNO126.7%

% from 52W High

CTKB-12.6%

TKNO-6.8%

% from 52W Low

CTKB64.0%

TKNO362.8%

Asset Turnover (TTM)

CTKB0.45x

TKNO0.43x

FCF Yield (TTM)

CTKB-1.7%

TKNO-1.6%

Earnings Yield (TTM)

CTKB-11.5%

TKNO-3.5%

Dividend Yield (TTM)

CTKBN/A

TKNON/A

Rule of 40

CTKB-0.4

TKNO-4.6

EV/GP/RG

CTKB0.61

TKNO2.35

Ticker research

View CTKB research View TKNO research

Metric	CTKB Cytek Biosciences Inc	TKNO Alpha Teknova Inc
Market & Valuation
Market Cap	$701M	$474M
Enterprise Value	$637M	$481M
Price	$5.43	$8.84
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	10.84x
EV/Sales	3.08x	11.01x
EV/EBITDA	1,027.69x	0.00x
P/B Ratio	2.37x	7.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-65.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	9.58x
Revenue & Growth
Revenue (TTM)	$207M	$44M
Revenue Growth (YoY)	5.4%	12.3%
Forward Rev Growth	6.1%	14.4%
Profitability
Gross Margin (TTM)	53.2%	34.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-21.7%
Net Margin (TTM)	-39.0%	-38.4%
FCF Margin (TTM)	-5.9%	-16.8%
Net Income (TTM)	$-81M	$-17M
FCF (TTM)	$-12M	$-7M
EPS (TTM)	-$0.62	-$0.31
ROE (TTM)	-2353.0%	-2494.0%
ROA (TTM)	-1740.0%	-1653.0%
ROIC (TTM)	-2293.0%	-2086.0%
Financial Health
Cash	$74M	$6M
Debt	$10M	$13M
Net Cash/Debt	$64M	$-7M
Current Ratio (TTM)	4.48x	4.49x
Quick Ratio (TTM)	3.77x	3.32x
Debt/Equity (TTM)	0.03x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	0.93
52W Performance	39.2%	66.5%
YTD Performance	10.4%	126.7%
% from 52W High	-12.6%	-6.8%
% from 52W Low	64.0%	362.8%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.43x
FCF Yield (TTM)	-1.7%	-1.6%
Earnings Yield (TTM)	-11.5%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-4.6
EV/GP/RG	0.61	2.35
Ticker research	View CTKB research	View TKNO research